Viewing nowShubastin Tablet 20 Milligrams (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

MFDS item code 201504203 · Approved 2015.06.29 · Insurance code 658202860
Treatment for hypercholesterolemia and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct to diet for patients with primary hypercholesterolemia and mixed dyslipidemia. It is also administered in combination with dietary changes or lipid-lowering therapy for patients with homozygous familial hypercholesterolemia. It effectively lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis. In pediatric patients, it helps reduce cholesterol levels when LDL cholesterol levels are high despite strict dietary restrictions. Additionally, it is used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Furthermore, in high-risk cardiovascular disease patients with elevated high-sensitivity C-reactive protein levels, it is used to reduce the risk associated with stroke, myocardial infarction, and arterial revascularization. Therefore, this medication is effectively used for various types of dyslipidemia and the reduction of cardiovascular risk.
Can be administered at any time of day regardless of meals. The initial dose is 5 milligrams once daily and can be adjusted to a maintenance dose to achieve further LDL cholesterol reduction as needed. The maintenance dose is typically 10 milligrams once daily, which is effective for most patients. This maintenance dose may be adjusted at intervals of 4 weeks or more based on LDL cholesterol levels, therapeutic goals, and patient response.
The usual dosage range is once daily 5 milligrams to 20 milligrams. The dose is individually adjusted based on the recommended therapeutic goals for each patient. The dosage should be adjusted at intervals of 4 weeks or more.
This medication should not be administered to certain patients. For example, it should not be used in patients with an allergy to any component of this medication, those with severe liver impairment, patients with muscle disorders, patients taking certain immunosuppressants, patients with severe renal impairment, pregnant or breastfeeding women, and women of childbearing age who are not using adequate contraception. Additionally, high-dose administration is prohibited in patients at high risk for muscle disorders. Risk factors include moderate renal impairment, hypothyroidism, family history of muscle disorders, and alcohol abuse. This medication contains lactose, therefore it should not be taken by patients with lactose intolerance. Caution should be exercised in patients who consume excessive alcohol or have a history of liver disease, and regular liver function tests are recommended. If symptoms such as myalgia, muscle weakness, or cramps occur, the physician should be informed immediately, and if necessary, blood tests should be conducted to check for muscle damage. If severe muscle damage is suspected, the medication should be discontinued. In cases of acute severe illness or after surgery, or if there are severe metabolic disorders, the administration of this medication should be halted. Rarely, this medication can cause severe skin reactions or liver damage, so if any rashes, jaundice, or severe fatigue occur, treatment should be stopped immediately and a physician should be consulted. This medication may interact with various other drugs, so if other medications are being taken, it is essential to inform the physician or pharmacist. In particular, the risk of muscle damage may increase when used concurrently with certain antiviral drugs, immunosuppressants, antibiotics, and lipid-lowering agents. Women who are pregnant or planning to become pregnant should not take this medication, and if pregnancy occurs while taking it, the medication should be immediately discontinued. Nursing women should also refrain from using this medication. In case of overdose, there are no specific antidotes, so appropriate treatment and monitoring will be necessary based on the symptoms. Care should be taken when driving or operating machinery as dizziness may occur. This medication may exhibit higher plasma concentrations in Asian individuals, hence dosage adjustments may be necessary. It is important to regularly check liver function and muscle-related tests for abnormalities while taking this medication.
Allergic reactions including hives and angioedema, Stevens-Johnson syndrome, eosinophilia and systemic symptoms induced drug reaction syndrome (DRESS), rhabdomyolysis, severe myopathy, oculomotor palsy, acute renal failure, oliguria, jaundice, hepatitis, severe allergic reactions, severe skin abnormal reactions, dyspnea, liver abnormalities (jaundice), severe neurological symptoms, severe edema or urinary abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius.
Pink round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.